Adhera Therapeutics, Inc. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Adhera Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q3 2023.
  • Adhera Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2023 was -$269K, a 50.8% increase year-over-year.
  • Adhera Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2023 was -$1.28M, a 12.3% increase year-over-year.
  • Adhera Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$1.62M, a 140% decline from 2021.
  • Adhera Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$674K, a 66.9% increase from 2020.
  • Adhera Therapeutics, Inc. annual Operating Income (Loss) for 2020 was -$2.04M, a 82% increase from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 -$1.28M -$269K +$278K +50.8% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-20
Q2 2023 -$1.56M -$296K +$153K +34.1% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-21
Q1 2023 -$1.71M -$353K -$93K -35.8% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-22
Q4 2022 -$1.62M -$361K -$158K -78% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-31
Q3 2022 -$1.46M -$548K -$316K -136% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-20
Q2 2022 -$1.14M -$449K -$320K -248% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-21
Q1 2022 -$824K -$260K -$150K -136% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-22
Q4 2021 -$674K -$203K -$39K -23.8% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$635K -$232K -$38K -19.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$597K -$129K +$227K +63.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$824K -$110K +$1.21M +91.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$2.04M -$164K +$3.59M +95.6% Oct 1, 2020 Dec 31, 2020 10-K 2022-04-15
Q3 2020 -$5.63M -$194K +$2.03M +91.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-22
Q2 2020 -$7.66M -$356K +$2.42M +87.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-23
Q1 2020 -$10.1M -$1.32M +$1.24M +48.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-24
Q4 2019 -$11.3M -$3.76M -$723K -23.9% Oct 1, 2019 Dec 31, 2019 10-K 2021-04-07
Q3 2019 -$10.6M -$2.22M +$5.56M +71.4% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-18
Q2 2019 -$16.1M -$2.78M +$989K +26.2% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-19
Q1 2019 -$17.1M -$2.56M -$1.34M -110% Jan 1, 2019 Mar 31, 2019 10-Q 2020-07-06
Q4 2018 -$15.8M -$3.03M +$107K +3.41% Oct 1, 2018 Dec 31, 2018 10-K 2020-04-14
Q3 2018 -$15.9M -$7.78M -$6.74M -651% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-19
Q2 2018 -$9.16M -$3.77M -$2.82M -297% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$6.34M -$1.22M -$249K -25.8% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 -$6.09M -$3.14M -$2.72M -652% Oct 1, 2017 Dec 31, 2017 10-K 2019-04-16
Q3 2017 -$3.37M -$1.04M -$938K -960% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-19
Q2 2017 -$2.43M -$949K -$820K -639% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-10
Q1 2017 -$1.61M -$967K -$853K -747% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-18
Q4 2016 -$758K -$417K -$2.68M -118% Oct 1, 2016 Dec 31, 2016 10-K 2018-04-17
Q3 2016 $1.92M -$97.7K +$934K +90.5% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
Q2 2016 $987K -$128K +$894K +87.4% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 $93.2K -$114K +$1.2M +91.3% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 -$1.11M $2.26M +$2.94M Oct 1, 2015 Dec 31, 2015 10-K 2017-03-31
Q3 2015 -$4.05M -$1.03M +$575K +35.8% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-21
Q2 2015 -$4.62M -$1.02M -$351K -52.3% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
Q1 2015 -$4.27M -$1.32M -$752K -134% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16
Q4 2014 -$3.52M -$679K -$702K -3052% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-30
Q3 2014 -$2.82M -$1.61M -$1.73M -1396% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-16
Q2 2014 -$1.09M -$671K -$485K -261% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 -$602K -$563K -$237K -72.7% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q4 2013 -$365K $23K +$1.51M Oct 1, 2013 Dec 31, 2013 10-K 2015-02-18
Q3 2013 -$1.87M $124K +$1.82M Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-14
Q2 2013 -$3.69M -$186K +$341K +64.7% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-19
Q1 2013 -$4.03M -$326K +$3.85M +92.2% Jan 1, 2013 Mar 31, 2013 10-Q 2014-08-19
Q4 2012 -$7.88M -$1.49M +$17.2M +92% Oct 1, 2012 Dec 31, 2012 10-K 2014-08-05
Q3 2012 -$25.1M -$1.69M +$3.93M +69.9% Jul 1, 2012 Sep 30, 2012 10-Q 2014-08-07
Q2 2012 -$29M -$527K +$4.92M +90.3% Mar 31, 2012 Jun 30, 2012 10-Q 2014-08-07
Q1 2012 -$33.9M -$4.18M +$1.09M +20.6% Jan 1, 2012 Mar 31, 2012 10-Q 2014-08-07
Q4 2011 -$35M -$18.7M Oct 1, 2011 Dec 31, 2011 10-K 2014-07-22
Q3 2011 -$5.63M +$5.16M +47.8% Jul 1, 2011 Sep 30, 2011 10-Q 2012-12-05
Q2 2011 -$5.45M +$703K +11.4% Apr 1, 2011 Jun 30, 2011 10-Q 2012-12-05
Q1 2011 -$5.27M Jan 1, 2011 Mar 31, 2011 10-Q 2012-12-05
Q3 2010 -$10.8M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-10
Q2 2010 -$6.15M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.